A fuller picture on remdesivir is expected any day now. Gilead has said that it will release data from one of its U.S. trials — the one from which the Chicago results were disclosed — by the end of this week. Even more data, from other trials including the China study, could follow shortly thereafter.
Control group are those at the same hospital that did not receive the drug. I'm going to use that data and run it six degrees of bacon! Scott will do the same!
Market Data 
Markets 
AI
